University of Bayreuth
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1975-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.uni-bayreuth.de
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring in Patients with Lung Cancer
Not Applicable
Recruiting
- Conditions
- Lung CancerQuality of Life
- First Posted Date
- 2024-02-09
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- University of Bayreuth
- Target Recruit Count
- 220
- Registration Number
- NCT06252233
- Locations
- 🇩🇪
Caritas Krankenhaus St. Maria Donaustauf, Donaustauf, Germany
🇩🇪Klinikum St. Elisabeth Straubing, Straubing, Germany
🇩🇪Klinikum Bamberg, Bamberg, Germany
News
GLP-1 Drugs Alter Taste Perception, Enhancing Sweetness and Saltiness to Support Appetite Control
About one in five patients taking GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro experience enhanced perception of sweetness and saltiness, which correlates with improved appetite control and satiety.